Effect of zoledronic acid and amputation on bone invasion and lung metastasis of canine osteosarcoma in nude mice

Clinical and Experimental Metastasis

Volumn 28, Issue 4, 2011, Pages 377-389

  Wolfe, Tobie D ^a   Pillai, Smitha Pankajavally Somanathan ^a   Hildreth III, Blake Eason ^a   Lanigan, Lisa G ^a   Martin, Chelsea K ^a   Werbeck, Jillian L ^a   Rosol, Thomas J ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Bone lysis; Canine; Dog; Metastasis; Nude mice; Osteosarcoma; Zoledronic acid

Indexed keywords

ZOLEDRONIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BONE PAIN; CANCER INVASION; CANCER PALLIATIVE THERAPY; CANCER RISK; CONTROLLED STUDY; DOG; DRUG EFFECT; FEMALE; GENERAL ANESTHESIA; HISTOPATHOLOGY; LEG AMPUTATION; LUNG METASTASIS; METAPHYSIS; MONOTHERAPY; MOUSE; NONHUMAN; OSTEOLYSIS; OSTEOSARCOMA; TIBIA; TUMOR GROWTH;

AMPUTATION; ANIMALS; ANTINEOPLASTIC AGENTS; BONE NEOPLASMS; DIPHOSPHONATES; DOG DISEASES; DOGS; FEMALE; IMIDAZOLES; LUNG NEOPLASMS; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; OSTEOSARCOMA; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 79955523855     PISSN: 02620898     EISSN: 15737276     Source Type: Journal    
DOI: 10.1007/s10585-011-9377-9     Document Type: Article

References (53)

1. SK Dorfman AI Hurvitz AK Patnaik 1977 Primary and secondary bone tumours in the dog J Small Anim Pract 18 313 326 267798 1:STN:280:DyaE2s3jtFehsQ%3D%3D 10.1111/j.1748-5827.1977.tb05890.x (Pubitemid 8115622)
2. LB Evans 1983 Osteosarcoma in a young Great Dane dog J S Afr Vet Assoc 54 271 273 6583421 1:STN:280:DyaL2c7jvVGgsw%3D%3D
3. R Chun LP de Lorimier 2003 Update on the biology and management of canine osteosarcoma Vet Clin N Am Small Anim Pract 33 491 516 10.1016/S0195-5616(03) 00021-4 (Pubitemid 36798634)
4. SJ Withrow BE Powers RC Straw RM Wilkins 1991 Comparative aspects of osteosarcoma. Dog versus man Clin Orthop Relat Res 270 159 168 1884536
5. FW Spiers AH Beddoe 1983 Sites of incidence of osteosarcoma in the long bones of man and the beagle Health Phys 44 Suppl 1 49 64 6575001
6. RS Brodey IJ Fidler S Bech-Nielsen 1975 Correlation of in vitro immune response with clinical course of malignant neoplasia in dogs Am J Vet Res 36 75 80 1054221 1:STN:280:DyaE2M7gslegtg%3D%3D
7. WF Enneking 1975 Editorial: Osteosarcoma Clin Orthop Relat Res 111 2 4 1057463 10.1097/00003086-197509000-00001
8. JM Liptak WS Dernell RC Straw SA Rizzo MH Lafferty SJ Withrow 2004 Proximal radial and distal humeral osteosarcoma in 12 dogs J Am Anim Hosp Assoc 40 461 467 15533966 (Pubitemid 43180222)
9. K Ebata 1982 Diagnostic imaging of skeletal disorders, with special reference to systemic diagnosis of malignant bone tumors Nippon Ika Daigaku Zasshi 49 601 608 6216266 1:STN:280:DyaL3s%2FlslegtA%3D%3D
10. JM Liptak GE Pluhar WS Dernell SJ Withrow 2005 Limb-sparing surgery in a dog with osteosarcoma of the proximal femur Vet Surg 34 71 77 15720600 10.1111/j.1532-950X.2005.00013.x (Pubitemid 41615397)
11. N Ehrhart 2005 Longitudinal bone transport for treatment of primary bone tumors in dogs: technique description and outcome in 9 dogs Vet Surg 34 24 34 15720593 10.1111/j.1532-950X.2005.00005.x (Pubitemid 41615390)
12. GJ Spodnick J Berg WM Rand SH Schelling G Couto HJ Harvey RA Henderson G MacEwen N Mauldin DL McCaw 1992 Prognosis for dogs with appendicular osteosarcoma treated by amputation alone: 162 cases (1978-1988) J Am Vet Med Assoc 200 995 999 1577656 1:STN:280:DyaK383ltVeksg%3D%3D
13. EP Spugnini B Vincenzi G Caruso A Baldi G Citro D Santini G Tonini 2009 Zoledronic acid for the treatment of appendicular osteosarcoma in a dog J Small Anim Pract 50 44 46 18793253 1:STN:280:DC%2BD1M%2Fos1Oqtg%3D%3D 10.1111/j.1748-5827.2008.00635.x
14. RE Coleman 2004 Bisphosphonates: clinical experience Oncologist 9 Suppl 4 14 27 15459426 1:CAS:528:DC%2BD2cXpslGhtbs%3D 10.1634/theoncologist.9-90004-14 (Pubitemid 39363165)
15. A Labrinidis S Hay V Liapis V Ponomarev DM Findlay A Evdokiou 2009 Zoledronic acid inhibits both the osteolytic and osteoblastic components of osteosarcoma lesions in a mouse model Clin Cancer Res 15 3451 3461 19401351 1:CAS:528:DC%2BD1MXmtVKlsr4%3D 10.1158/1078-0432.CCR-08-1616
16. B Ory MF Heymann A Kamijo F Gouin D Heymann F Redini 2005 Zoledronic acid suppresses lung metastases and prolongs overall survival of osteosarcoma-bearing mice Cancer 104 2522 2529 16270320 1:CAS:528: DC%2BD2MXhtlWgt7fO 10.1002/cncr.21530 (Pubitemid 41691577)
17. MM Tomayko CP Reynolds 1989 Determination of subcutaneous tumor size in athymic (nude) mice Cancer Chemother Pharmacol 24 148 154 2544306 1:STN:280:DyaL1M3ovVGjug%3D%3D 10.1007/BF00300234 (Pubitemid 19163397)
18. G Bacci M Avella P Picci A Briccoli D Dallari M Campanacci 1988 Metastatic patterns in osteosarcoma Tumori 74 421 427 3055577 1:STN:280:DyaL1M%2FksFeitw%3D%3D
19. LA de Santos B Edeiken 1982 Purely lytic osteosarcoma Skeletal Radiol 9 1 7 10.1007/BF00367373 (Pubitemid 13196855)
20. AF Pelfrene 1985 A search for a suitable animal model for bone tumors: a review Drug Chem Toxicol 8 83 99 3926448 1:STN:280:DyaL2M3ls12qtw%3D%3D 10.3109/01480548509011636 (Pubitemid 15038771)
21. S Crnalic I Hakansson L Boquist R Lofvenberg LA Brostrom 1997 A novel spontaneous metastasis model of human osteosarcoma developed using orthotopic transplantation of intact tumor tissue into tibia of nude mice Clin Exp Metastasis 15 164 172 9062393 1:STN:280:DyaK2s3hs1WjsQ%3D%3D 10.1023/A:1018456911823 (Pubitemid 27157819)
22. O Berlin D Samid R Donthineni-Rao W Akeson D Amiel VL Woods Jr 1993 Development of a novel spontaneous metastasis model of human osteosarcoma transplanted orthotopically into bone of athymic mice Cancer Res 53 4890 4895 8402677 1:STN:280:DyaK2c%2Fgs1aqsg%3D%3D (Pubitemid 23326183)
23. S Miretti I Roato R Taulli C Ponzetto M Cilli M Olivero MF Di Renzo L Godio A Albini P Buracco R Ferracini 2008 A mouse model of pulmonary metastasis from spontaneous osteosarcoma monitored in vivo by luciferase imaging PLoS One 3 e1828 18350164 10.1371/journal.pone.0001828 (Pubitemid 351936289)
24. GT Selvarajah J Kirpensteijn ME van Wolferen NA Rao H Fieten JA Mol 2009 Gene expression profiling of canine osteosarcoma reveals genes associated with short and long survival times Mol Cancer 8 72 19735553 10.1186/1476-4598-8-72
25. AL Parodi 1982 Canine osteosarcoma as a model in comparative oncology Sem Hop 58 1731 1735 6291155 1:STN:280:DyaL3s%2FktFehtQ%3D%3D (Pubitemid 13236674)
26. J Yuan C Ossendorf JP Szatkowski JT Bronk A Maran M Yaszemski ME Bolander G Sarkar B Fuchs 2009 Osteoblastic and osteolytic human osteosarcomas can be studied with a new xenograft mouse model producing spontaneous metastases Cancer Invest 27 435 442 19212826 10.1080/07357900802491477
27. H Ilaslan J Schils W Nageotte SA Lietman M Sundaram 2010 Clinical presentation and imaging of bone and soft-tissue sarcomas Cleve Clin J Med 77 Suppl 1 S2 S7 20179183 10.3949/ccjm.77.s1.01
28. CK Tebbi J Gaeta 1988 Osteosarcoma Pediatr Ann 17 285 300 3290815 1:STN:280:DyaL1c3mt1ehsQ%3D%3D
29. F Lamoureux P Richard Y Wittrant S Battaglia P Pilet V Trichet F Blanchard F Gouin B Pitard D Heymann F Redini 2007 Therapeutic relevance of osteoprotegerin gene therapy in osteosarcoma: blockade of the vicious cycle between tumor cell proliferation and bone resorption Cancer Res 67 7308 7318 17671200 1:CAS:528:DC%2BD2sXosVemt70%3D 10.1158/0008-5472.CAN-06-4130 (Pubitemid 47206560)
30. F Lamoureux V Trichet C Chipoy F Blanchard F Gouin F Redini 2007 Recent advances in the management of osteosarcoma and forthcoming therapeutic strategies Expert Rev Anticancer Ther 7 169 181 17288528 1:CAS:528: DC%2BD2sXhvFWktb0%3D 10.1586/14737140.7.2.169 (Pubitemid 46277282)
31. F Lamoureux G Picarda J Rousseau C Gourden S Battaglia C Charrier B Pitard D Heymann F Redini 2008 Therapeutic efficacy of soluble receptor activator of nuclear factor-kappa B-Fc delivered by nonviral gene transfer in a mouse model of osteolytic osteosarcoma Mol Cancer Ther 7 3389 3398 18852142 1:CAS:528:DC%2BD1cXht1ensbzI 10.1158/1535-7163.MCT-08-0497
32. A Labrinidis S Hay V Liapis DM Findlay A Evdokiou 2010 Zoledronic acid protects against osteosarcoma-induced bone destruction but lacks efficacy against pulmonary metastases in a syngeneic rat model Int J Cancer 127 345 354 19924813 1:CAS:528:DC%2BC3cXmsVGntbk%3D
33. K Kimura T Nakano YB Park M Tani H Tsuda Y Beppu H Moriya J Yokota 2002 Establishment of human osteosarcoma cell lines with high metastatic potential to lungs and their utilities for therapeutic studies on metastatic osteosarcoma Clin Exp Metastasis 19 477 485 12405284 1:CAS:528:DC%2BD38Xnt1ags7s%3D 10.1023/A:1020395816633 (Pubitemid 35178665)
34. JJ Body 2006 Bisphosphonates for malignancy-related bone disease: current status, future developments Support Care Cancer 14 408 418 16450087 10.1007/s00520-005-0913-5
35. M Gatien O Benjamin G Berengere V Franck G Francois B Frederic R Francoise H Dominique 2010 Therapeutic approach of primary bone tumours by bisphosphonates Curr Pharm Des 16 2981 2987 10.2174/138161210793563554
36. KL Kavanagh K Guo JE Dunford X Wu S Knapp FH Ebetino MJ Rogers RG Russell U Oppermann 2006 The molecular mechanism of nitrogen-containing bisphosphonates as antiosteoporosis drugs Proc Natl Acad Sci USA 103 7829 7834 16684881 1:CAS:528:DC%2BD28XlsVGksL0%3D 10.1073/pnas.0601643103
37. A Hall CD Nobes 2000 Rho GTPases: molecular switches that control the organization and dynamics of the actin cytoskeleton Philos Trans R Soc Lond B Biol Sci 355 965 970 11128990 1:CAS:528:DC%2BD3cXmsVSqtrk%3D 10.1098/rstb.2000.0632 (Pubitemid 30613321)
38. T Yuasa S Kimura E Ashihara T Habuchi T Maekawa 2007 Zoledronic acid - a multiplicity of anti-cancer action Curr Med Chem 14 2126 2135 17691952 1:CAS:528:DC%2BD2sXptV2hs7c%3D 10.2174/092986707781389600 (Pubitemid 47578153)
39. JP Coxon GM Oades RS Kirby KW Colston 2004 Zoledronic acid induces apoptosis and inhibits adhesion to mineralized matrix in prostate cancer cells via inhibition of protein prenylation BJU Int 94 164 170 15217454 1:CAS:528:DC%2BD2cXmvVeiu74%3D 10.1111/j.1464-4096.2004.04831.x (Pubitemid 38980328)
40. RS Weinstein PK Roberson SC Manolagas 2009 Giant osteoclast formation and long-term oral bisphosphonate therapy N Engl J Med 360 53 62 19118304 1:CAS:528:DC%2BD1MXhvF2juw%3D%3D 10.1056/NEJMoa0802633
41. DB Kimmel 2007 Mechanism of action, pharmacokinetic and pharmacodynamic profile, and clinical applications of nitrogen-containing bisphosphonates J Dent Res 86 1022 1033 17959891 1:CAS:528:DC%2BD2sXhtleku7rE 10.1177/ 154405910708601102
42. TA Guise 2008 Antitumor effects of bisphosphonates: promising preclinical evidence Cancer Treat Rev 34 Suppl 1 S19 S24 18486348 1:CAS:528: DC%2BD1cXmvVOnsr0%3D 10.1016/j.ctrv.2008.03.006
43. CR Dass PF Choong 2007 Zoledronic acid inhibits osteosarcoma growth in an orthotopic model Mol Cancer Ther 6 3263 3270 18089720 1:CAS:528: DC%2BD2sXhsVCjsrrN 10.1158/1535-7163.MCT-07-0546
44. JT Buijs I Que CW Lowik SE Papapoulos G van der Pluijm 2009 Inhibition of bone resorption and growth of breast cancer in the bone microenvironment Bone 44 380 386 19041433 1:CAS:528:DC%2BD1MXhtFSmur4%3D 10.1016/j.bone.2008.10.047
45. ST Shu MV Nadella WP Dirksen SA Fernandez NK Thudi JL Werbeck MD Lairmore TJ Rosol 2007 A novel bioluminescent mouse model and effective therapy for adult T-cell leukemia/lymphoma Cancer Res 67 11859 11866 18089816 1:CAS:528:DC%2BD2sXhsVCjs7nM 10.1158/0008-5472.CAN-07-1701
46. NK Thudi CK Martin MVP Prasad SA Fernandez JL Werbeck JJ Pinzone TJ Rosol 2008 Zoledronic acid decreased osteolysis but not bone metastasis in a nude mouse model of canine prostate cancer with mixed bone lesions Prostate 68 1116 1125 18461562 1:CAS:528:DC%2BD1cXovFOgsrs%3D 10.1002/pros.20776 (Pubitemid 351875183)
47. CK Martin JL Werbeck NK Thudi LG Lanigan TD Wolfe RE Toribio TJ Rosol 2010 Zoledronic acid reduces bone loss and tumor growth in an orthotopic xenograft model of osteolytic oral squamous cell carcinoma Cancer Res 70 8607 8616 20959474 1:CAS:528:DC%2BC3cXhtlKjt77P 10.1158/0008-5472.CAN-10-0850
48. BJ Edwards M Gounder JM McKoy I Boyd M Farrugia C Migliorati R Marx S Ruggiero M Dimopoulos DW Raisch S Singhal K Carson E Obadina S Trifilio D West J Mehta CL Bennett 2008 Pharmacovigilance and reporting oversight in US FDA fast-track process: bisphosphonates and osteonecrosis of the jaw Lancet Oncol 9 1166 1172 19038763 10.1016/S1470-2045(08)70305-X
49. TA Guise 2006 Bone loss and fracture risk associated with cancer therapy Oncologist 11 1121 1131 17110632 1:CAS:528:DC%2BD28XhtlCmu73L 10.1634/theoncologist.11-10-1121 (Pubitemid 44788404)
50. NJ Bacon NP Ehrhart WS Dernell M Lafferty SJ Withrow 2008 Use of alternating administration of carboplatin and doxorubicin in dogs with microscopic metastases after amputation for appendicular osteosarcoma: 50 cases (1999-2006) J Am Vet Med Assoc 232 1504 1510 18479240 1:CAS:528: DC%2BD1cXntVOlsbw%3D 10.2460/javma.232.10.1504 (Pubitemid 351703453)
51. K Koto N Horie S Kimura H Murata T Sakabe T Matsui M Watanabe S Adachi T Maekawa S Fushiki T Kubo 2009 Clinically relevant dose of zoledronic acid inhibits spontaneous lung metastasis in a murine osteosarcoma model Cancer Lett 274 271 278 18986762 1:CAS:528:DC%2BD1MXns12qsw%3D%3D 10.1016/j.canlet.2008.09. 026
52. ID Kurzman F Shi DM Vail EG MacEwen 1999 In vitro and in vivo enhancement of canine pulmonary alveolar macrophage cytotoxic activity against canine osteosarcoma cells Cancer Biother Radiopharm 14 121 128 10850295 1:CAS:528:DyaK1MXjtVGjtLY%3D 10.1089/cbr.1999.14.121 (Pubitemid 29217791)
53. D Kabelitz D Wesch E Pitters M Zoller 2004 Characterization of tumor reactivity of human V gamma 9V delta 2 gamma delta T cells in vitro and in SCID mice in vivo J Immunol 173 6767 6776 15557170 1:CAS:528:DC%2BD2cXhtVShsb%2FJ (Pubitemid 39541063)